학술논문

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial
Document Type
Article
Source
In The Lancet Infectious Diseases August 2023 23(8):956-964
Subject
Primary Research
Articles
Language
ISSN
1473-3099